Cleared Traditional

K800159 - PHADEBACT STREP D TEST

K800159 is an FDA 510(k) clearance for PHADEBACT STREP D TEST, manufactured by Pharmacia, Inc.. The device is a Class 1 Microbiology device with product code GTZ cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K800159 · Pharmacia, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1980
Decision
96d
Days
Class 1
Risk

K800159 is an FDA 510(k) clearance for the PHADEBACT STREP D TEST. Classified as Antisera, All Groups, Streptococcus Spp. (product code GTZ), Class I - General Controls.

Submitted by Pharmacia, Inc. (Mchenry, US). The FDA issued a Cleared decision on April 29, 1980 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Microbiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Pharmacia, Inc. devices

FDA 510(k) Submission Details - K800159

510(k) Number K800159 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 24, 1980
Decision Date April 29, 1980
Days to Decision 96 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
6d faster than avg
Panel avg: 102d · This submission: 96d
Pathway characteristics
Predicate-based equivalence.

GTZ Device Classification - Class 1, General Controls

Product Code GTZ Antisera, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTZ Antisera, All Groups, Streptococcus Spp.

All 89
Devices cleared under the same product code (GTZ) and FDA review panel - the closest regulatory comparables to K800159.
MERITECASTREP (TM)
K821100 · Meridian Diagnostics, Inc. · May 1982
WELLCOGEN GROUP B
K820069 · Burroughs Wellcome Co. · Feb 1982
STREPTO-SEC TM
K801159 · Organon, Inc. · Jun 1980
STREP-TEX
K781607 · Burroughs Wellcome Co. · Oct 1978
TEST, ANTIBODIES FOR GRP A, LATEX SLIDE
K760033 · Gamma Biologicals, Inc. · Aug 1976